Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Cardiovascular disease is "unacceptably" high and increasing among American adults ages 20 to 44, requiring aggressive prevention.
Read Full NewsThe AAN's new guideline enhances diagnosis and management of functional seizures, emphasizing psychological interventions and addressing care gaps for better patient outcomes.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 30, 2026.
Mallon explains the shared risks linking celiac disease and type 1 diabetes and why early screening improves outcomes.
Nedelkopoulou emphasizes the importance of structured and multidisciplinary transition programs for young patients with IBD and HPB disease.
FDA Accepts Oxylanthanum Carbonate NDA Resubmission for Hyperphosphatemia in CKD, Dialysis
6 Nephrology Headlines You Missed In January 2026
OptIMMize-1: New Efficacy and Safety Data on Risankizumab in Pediatric Psoriasis
1.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
2.
A garden can save your life
3.
Screening for prostate cancer: is it time to give up digital rectal examination?
4.
No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy.
5.
Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy
1.
Exploring Digital Cognitive Stimulation for Elderly Breast Cancer Patients
2.
An Analytical and Statistical Journey through Genomic Revolution, Novel Therapeutics, and Future Horizons in Lymphoma 2025
3.
Understanding Neutropenic Fever: What It Is and Why it's a Serious Concern
4.
Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy
5.
Autophagy: A Double-Edged Sword in Cancer Development, Immune Evasion, and Drug Resistance
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
2.
Should We Use DARA Up Front As First-Line Therapy in MM?
3.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
5.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge